Table 4.

Comparison of the scores of PRO for migraine (FAS)

	Treatment group (n = 177)	Control group (n = 180)	P values
Total score
4w	29.68 ± 5.87	30.18 ± 5.86	0.767
8w	26.97 ± 6.72	26.79 ± 7.26	0.455
12 w	22.90 ± 6.63	23.80 ± 7.27	0.301
Follow-up period	21.61 ± 6.47	23.41 ± 6.80	0.021*
Headache
4w	10.88 ± 2.07	11.05 ± 2.24	0.725
8w	9.56 ± 2.62	9.52 ± 2.76	0.643
12 w	8.54 ± 2.78	8.23 ± 2.88	0.246
Follow-up period	7.95 ± 2.73	8.31 ± 2.98	0.283
Somatization symptoms
4w	9.46 ± 2.66	9.48 ± 2.48	0.022*
8w	8.83 ± 2.67	8.57 ± 2.72	0.340
12 w	7.62 ± 2.51	7.72 ± 2.65	0.660
Follow-up period	7.52 ± 2.49	7.61 ± 2.38	0.745
Psychological state
4w	4.26 ± 1.36	4.43 ± 1.45	0.650
8w	3.97 ± 1.36	4.14 ± 1.56	0.565
12w	3.51 ± 1.29	3.81 ± 1.39	0.086
Follow-up period	3.42 ± 1.24	3.72 ± 1.29	0.101
Functional status
4w	5.08 ± 1.41	5.22 ± 1.52	0.697
8w	4.61 ± 1.58	4.55 ± 1.63	0.442
12 w	3.23 ± 1.36	4.04 ± 1.59	P < 0.001*
Follow-up period	2.71 ± 1.16	3.77 ± 1.46	P < 0.001*

*P < 0.05 for data comparison between groups aftertreatment